Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) – HC Wainwright raised their Q2 2023 earnings per share estimates for Paratek Pharmaceuticals in a report issued on Wednesday, May 10th. HC Wainwright analyst E. Arce now anticipates that the specialty pharmaceutical company will earn ($0.30) per share for the quarter, up from their previous forecast of […]
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) – Equities researchers at HC Wainwright lowered their Q1 2023 earnings estimates for Paratek Pharmaceuticals in a report issued on Monday, March 20th. HC Wainwright analyst E. Arce now forecasts that the specialty pharmaceutical company will post earnings per share of ($0.27) for the quarter, down from their […]
Analysts expect that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) will announce ($0.35) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Paratek Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.35) and the highest estimate coming in at ($0.34). Paratek Pharmaceuticals reported earnings […]